Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Peter G. Rose's publication output changed over time?
ScholarIQpublication output · 1998–2023
Output grew100% over the shown period — from 1 works in 1998 to 2 in 2023.
1
2
1
1
2
1
1
1
2
199819992000200420072008201120162023
What are the most-cited papers on Peter G. Rose?
ScholarIQmost cited works
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
Peter G. Rose, Brian N. Bundy, E. Blake Watkins, J.T. Thigpen, Günther Deppe, Mitchell Maiman, Daniel L. Clarke‐Pearson, Sam J. Insalaco
New England Journal of Medicine. 19992,684 CitationsOPEN ACCESS
Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
William E. Winter, G. Larry Maxwell, Chunqiao Tian, Jay W. Carlson, Robert F. Ozols, Peter G. Rose, Maurie Markman, Deborah K. Armstrong, Franco M. Muggia, William P. McGuire
Journal of Clinical Oncology. 2007850 CitationsOPEN ACCESS
Tumor Residual After Surgical Cytoreduction in Prediction of Clinical Outcome in Stage IV Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
William E. Winter, G. Larry Maxwell, Chunqiao Tian, Michael J. Sundborg, G. Scott Rose, Peter G. Rose, Stephen C. Rubin, Franco M. Muggia, William P. McGuire
Journal of Clinical Oncology. 2007405 CitationsOPEN ACCESS
Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study.
Peter G. Rose, John A. Blessing, Andrew R. Mayer, H D Homesley
Journal of Clinical Oncology. 1998404 Citations
Secondary Surgical Cytoreduction for Advanced Ovarian Carcinoma
Peter G. Rose, Stacy Nerenstone, Mark F. Brady, Daniel L. Clarke‐Pearson, George J. Olt, Stephen C. Rubin, David H. Moore, James M. Small
New England Journal of Medicine. 2004401 CitationsOPEN ACCESS
Related on ScholarIQ
Cleveland Clinic
Institution
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
Paper
Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
Paper
Tumor Residual After Surgical Cytoreduction in Prediction of Clinical Outcome in Stage IV Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
Paper
Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study.
Paper
Secondary Surgical Cytoreduction for Advanced Ovarian Carcinoma
Paper